{"date":"2026-11-12","count":57,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-11-12-2140-xo2pc7","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"21:40:41","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-11-12 21:40，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-11-12-2140-1l2efok","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"21:40:16","subject":"公告董事會決議通過增資盧森堡子公司Lotus Investment Holding SARL","clause":"第20款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-11-12 21:40，「公告董事會決議通過增資盧森堡子公司Lotus Investment Holding SARL」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-11-12-2139-5z0aft","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"21:39:51","subject":"公告本公司向Innobic (Asia) Co., Ltd.借款，額度最高不超過美金一億元","clause":"第51款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-11-12 21:39，「公告本公司向Innobic (Asia) Co., Ltd.借款，額度最高不超過美金一億元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-11-12-2139-1wxugue","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"21:39:11","subject":"公告本公司董事會決議通過115年第三季財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-11-12 21:39，「公告本公司董事會決議通過115年第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-11-12-2108-1j12agw","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"21:08:49","subject":"本公司115年第3季合併財務報告已提報董事會","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-11-12 21:08，「本公司115年第3季合併財務報告已提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-12-2033-1l3azgs","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:33:24","subject":"代孫公司United Orthopedic Corporation (Suisse) SA依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-12 20:33，「代孫公司United Orthopedic Corporation (Suisse) SA依公開發行公司資金貸與及背書保」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-12-2032-10lqs79","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:32:54","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-12 20:32，「依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-12-2029-1g7inko","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:29:08","subject":"代重要子公司UOC Europe Holding SA公告投資設立義大利銷售營運據點案","clause":"第15款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-12 20:29，「代重要子公司UOC Europe Holding SA公告投資設立義大利銷售營運據點案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-12-2027-37n2dy","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:27:18","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-12 20:27，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-11-12-2026-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:26:54","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-11-12 20:26，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2026-11-12-2026-tzaprt","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"20:26:18","subject":"公告本公司董事會決議買回本公司股份並辦理轉讓員工","clause":"第35款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2026-11-12 20:26，「公告本公司董事會決議買回本公司股份並辦理轉讓員工」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-11-12-1913-162tb6i","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"19:13:05","subject":"本公司受邀參加花旗環球證券之2026Q3線上法說會議","clause":"第12款","fact_date":"2026-11-13","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-11-12 19:13，「本公司受邀參加花旗環球證券之2026Q3線上法說會議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-11-12-1847-1r6luiy","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"18:47:15","subject":"本公司民國115年現金增資股款催繳公告","clause":"第44款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-11-12 18:47，「本公司民國115年現金增資股款催繳公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-11-12-1846-1tvx95h","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"18:46:37","subject":"公告本公司115年現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜","clause":"第37款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-11-12 18:46，「公告本公司115年現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-11-12-1845-ky9g35","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"18:45:39","subject":"公告本公司董事會決議辦理私募普通股","clause":"第11款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-11-12 18:45，「公告本公司董事會決議辦理私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-11-12-1841-fp0wno","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"18:41:06","subject":"公告本公司財務主管、會計主管、公司治理主管、 代理發言人經董事會委任通過","clause":"第8款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-11-12 18:41，「公告本公司財務主管、會計主管、公司治理主管、 代理發言人經董事會委任通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-11-12-1840-u9u0d","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"18:40:21","subject":"公告本公司115年第三季財務報告經審計委員會同意，並提董事會決議通過","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-11-12 18:40，「公告本公司115年第三季財務報告經審計委員會同意，並提董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7924-2026-11-12-1819-691dvn","company_id":"7924","company":"TLC-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"18:19:28","subject":"公告本公司董事會決議通過115年第3季合併財務報告","clause":"第43款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：TLC-KY（7924），2026-11-12 18:19，「公告本公司董事會決議通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2026-11-12-1739-dqg63m","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:39:00","subject":"本公司因有重大訊息待公布，經櫃買中心同意自115年11月13日起暫停交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2026-11-12 17:39，「本公司因有重大訊息待公布，經櫃買中心同意自115年11月13日起暫停交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-11-12-1738-5k40r1","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:38:00","subject":"公告本公司LT3001治療急性缺血性中風之新成份新藥，LT3001-203併用器械取栓之二期臨床試驗提前終止及結果分析","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-11-12 17:38，「公告本公司LT3001治療急性缺血性中風之新成份新藥，LT3001-203併用器械取栓之二期臨床試驗提前終止及結果分析」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-11-12-1732-itqmci","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:32:00","subject":"公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-11-12 17:32，「公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-11-12-1732-1r5rih6","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:32:00","subject":"公告本公司提報董事會115年度第3季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-11-12 17:32，「公告本公司提報董事會115年度第3季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2026-11-12-1724-1mv126e","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"17:24:00","subject":"公告本公司受邀參加華南永昌綜合證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2026-11-12 17:24，「公告本公司受邀參加華南永昌綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-11-12-1719-1z8vhn","company_id":"6467","company":"泰合","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"17:19:00","subject":"公告本公司董事會決議設置永續發展委員會暨委任第一屆永續發展委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-11-12 17:19，「公告本公司董事會決議設置永續發展委員會暨委任第一屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-11-12-1719-1ovyyhu","company_id":"6467","company":"泰合","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"17:19:00","subject":"公告本公司115年第三季財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-11-12 17:19，「公告本公司115年第三季財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2026-11-12-1718-m473nb","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:18:00","subject":"公告本公司FB825取得日本高濃度抗體製劑專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2026-11-12 17:18，「公告本公司FB825取得日本高濃度抗體製劑專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-11-12-1710-p2bocg","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:10:00","subject":"本公司新增背書保證金額達公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-11-12 17:10，「本公司新增背書保證金額達公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-11-12-1708-tiu8dd","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"17:08:00","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-11-12 17:08，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-11-12-1700-5rax5d","company_id":"6467","company":"泰合","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"17:00:26","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第11款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-11-12 17:00，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-11-12-1653-2460pt","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"16:53:29","subject":"公告本公司取得經濟部智慧財產局台灣新型專利核准領證通知書","clause":"第53款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-11-12 16:53，「公告本公司取得經濟部智慧財產局台灣新型專利核准領證通知書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-11-12-1650-z2kzlb","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"16:50:26","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-11-12 16:50，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-11-12-1648-ldbtny","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"16:48:34","subject":"公告本公司會計主管及代理發言人異動","clause":"第8款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-11-12 16:48，「公告本公司會計主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-11-12-1647-z2kzlb","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"16:47:46","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-11-12 16:47，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-11-12-1629-16ku9lc","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"16:29:34","subject":"公告本公司董事會通過115年第三季財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-11-12 16:29，「公告本公司董事會通過115年第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-11-12-1615-157eq3w","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"16:15:25","subject":"更正本公司115年9月背書保證資訊揭露明細表","clause":"第44款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-11-12 16:15，「更正本公司115年9月背書保證資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-11-12-1614-tiu8dd","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"16:14:01","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"第43款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-11-12 16:14，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-11-12-1606-z2kzlb","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"16:06:24","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第43款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-11-12 16:06，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-11-12-1557-i2tsjh","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:57:59","subject":"本公司董事會通過將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」","clause":"第6款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-11-12 15:57，「本公司董事會通過將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-11-12-1556-lnleyq","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:56:58","subject":"本公司董事會通過研發主管任命案","clause":"第8款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-11-12 15:56，「本公司董事會通過研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-11-12-1556-1xd71q3","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:56:30","subject":"本公司董事會通過115年度第3季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-11-12 15:56，「本公司董事會通過115年度第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-11-12-1555-1xniydi","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:55:56","subject":"本公司董事會通過高活性針劑充填線擴建案","clause":"第15款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-11-12 15:55，「本公司董事會通過高活性針劑充填線擴建案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-11-12-1541-1h3ceio","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:41:36","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-11-12 15:41，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2026-11-12-1537-tiu8dd","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"15:37:58","subject":"公告本公司董事會通過115年第3季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2026-11-12 15:37，「公告本公司董事會通過115年第3季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-11-12-1531-13snb5t","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"15:31:52","subject":"公告本公司向新加坡衛生科學局(HSA)提交安特羅腸病毒71型疫苗新藥審查(NDA)","clause":"第44款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-11-12 15:31，「公告本公司向新加坡衛生科學局(HSA)提交安特羅腸病毒71型疫苗新藥審查(NDA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-11-12-1522-1sp9mjr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-11-12","time":"15:22:14","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Corp.","clause":"第17款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-11-12 15:22，「代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Cor」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-11-12-1457-1dmzej5","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"14:57:08","subject":"公告本公司董事會通過策略長委任案","clause":"第8款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-11-12 14:57，「公告本公司董事會通過策略長委任案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-11-12-1453-1br977h","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"14:53:09","subject":"公告本公司決議設立印度分公司","clause":"第53款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-11-12 14:53，「公告本公司決議設立印度分公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2026-11-12-1451-1i1b61d","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"14:51:45","subject":"本公司民國115年度第三季合併財務報告業經董事會決議通過","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2026-11-12 14:51，「本公司民國115年度第三季合併財務報告業經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-11-12-1449-130bg9o","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"14:49:51","subject":"公告本公司董事會通過115年第三季合併財報","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-11-12 14:49，「公告本公司董事會通過115年第三季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-11-12-1433-13lxx5m","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"14:33:33","subject":"更正本公司115年9月關係人交易申報資訊","clause":"第51款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-11-12 14:33，「更正本公司115年9月關係人交易申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4123-2026-11-12-1430-17ezlvn","company_id":"4123","company":"晟德","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"14:30:28","subject":"公告本公司董事會通過115年度第三季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：晟德（4123），2026-11-12 14:30，「公告本公司董事會通過115年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2026-11-12-1419-pirb3e","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"14:19:29","subject":"公告本公司受邀參加元大證券舉辦之線上法說會","clause":"第12款","fact_date":"2026-11-13","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2026-11-12 14:19，「公告本公司受邀參加元大證券舉辦之線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2026-11-12-1407-16ku9lc","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"14:07:23","subject":"公告本公司董事會通過115年第三季財務報告","clause":"第31款","fact_date":"2026-11-11","cite_as":"公開資訊觀測站重大訊息：華安（6657），2026-11-12 14:07，「公告本公司董事會通過115年第三季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-11-12-1346-1nnt8f1","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"13:46:02","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-11-12 13:46，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-11-12-1343-uc1g5w","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"13:43:16","subject":"本公司董事會決議庫藏股註銷減資基準日","clause":"第11款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-11-12 13:43，「本公司董事會決議庫藏股註銷減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-11-12-1340-z2kzlb","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-11-12","time":"13:40:51","subject":"公告本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-11-12 13:40，「公告本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-11-12-1335-od8ekh","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-11-12","time":"13:35:21","subject":"本公司董事會通過115年第三季合併財務報告","clause":"第31款","fact_date":"2026-11-12","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-11-12 13:35，「本公司董事會通過115年第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}